GPN1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.077600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.328500E-02
Normal-vs-Stage2
5.615400E-01
Normal-vs-Stage3
9.398200E-02
Normal-vs-Stage4
4.004600E-01
Stage1-vs-Stage2
3.979200E-01
Stage1-vs-Stage3
3.312800E-01
Stage1-vs-Stage4
2.487600E-02
Stage2-vs-Stage3
1.211200E-01
Stage2-vs-Stage4
9.008400E-02
Stage3-vs-Stage4
3.598300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.540200E-01
Normal-vs-AfricanAmerican
6.566200E-01
Normal-vs-Asian
5.443200E-03
Caucasian-vs-AfricanAmerican
8.412000E-01
Caucasian-vs-Asian
8.759900E-03
AfricanAmerican-vs-Asian
3.474600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.998200E-01
Normal-vs-Female
3.718600E-01
Male-vs-Female
6.073000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.067000E-01
Normal-vs-Age(41-60Yrs)
9.293000E-01
Normal-vs-Age(61-80Yrs)
2.753400E-01
Normal-vs-Age(81-100Yrs)
7.494600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.935800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.964000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.678600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.477100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.287200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.574990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.400800E-01
Normal-vs-Daily Drinker
4.338400E-01
Normal-vs-Weekly Drinker
4.819600E-01
Normal-vs-Occasional Drinker
9.548200E-01
Normal-vs-Social Drinker
6.092800E-01
Non Drinker-vs-Daily Drinker
7.618200E-01
Non Drinker-vs-Weekly Drinker
5.020000E-01
Non Drinker-vs-Occasional Drinker
1.950020E-02
Non Drinker-vs-Social Drinker
3.671400E-01
Daily Drinker-vs-Weekly Drinker
7.579400E-01
Daily Drinker-vs-Occasional Drinker
9.705500E-02
Daily Drinker-vs-Social Drinker
6.128000E-01
Weekly Drinker-vs-Occasional Drinker
1.905180E-01
Weekly Drinker-vs-Social Drinker
8.423400E-01
Occasional Drinker-vs-Social Drinker
2.967200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.500200E-01
Normal-vs-Grade 2
3.275000E-01
Normal-vs-Grade 3
6.432600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.597100E-03
Grade 1-vs-Grade 3
8.49580000000794E-05
Grade 1-vs-Grade 4
9.500200E-01
Grade 2-vs-Grade 3
1.197850E-01
Grade 2-vs-Grade 4
3.275000E-01
Grade 3-vs-Grade 4
6.432600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.150400E-01
Normal-vs-NonDiabetic
4.938600E-01
Diabetic-vs-NonDiabetic
8.388200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.236400E-01
Normal-vs-NoPancreatitis
5.017400E-01
Pancreatitis-vs-NoPancreatitis
5.038600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.850600E-01
Normal-vs-N1
5.989000E-01
N0-vs-N1
3.661200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.772000E-01
Normal-vs-TP53-NonMutant
2.042200E-01
TP53-Mutant-vs-TP53-NonMutant
1.51483999999424E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
